Paper - WANFANG MED ONLINE

You Position: Home > Paper

Advance in the relationship between thyroid function and liver diseases

( views:0, downloads:0 )

Author:: No author available

Journal Title:: WORLD CHINESE JOURNAL OF DIGESTOLOGY

Issue:: 12

DOI:: 10.3969/j.issn.1009-3079.2009.12.001

Key Word:: 甲状腺;肝脏疾病;甲状腺机能亢进;乙型肝炎病毒;丙型肝炎病毒

Abstract：甲状腺疾病可影响肝脏及肝脏疾病,肝脏疾病(尤其严重的肝脏疾病)又可影响到甲状腺功能.干扰素治疗慢性病毒性肝炎时,可有甲状腺功能改变.临床医师在诊治患者肝脏疾病时,应注意甲状腺与肝脏疾病之间的相互关系.

Reference

[1].病毒性肝炎防治方案[J].2000,(6).
[2]黄斌,谭再海,候振宇.慢性乙型肝炎甲状腺激素水平与肝病理改变的相关性[J].2006,(6).
[3]何芳,苏劲波,蒋建家.甲状腺机能亢进症合并肝损害112例临床分析[J].2006,(4).
[4]王方剑,王昶,马丽萍,等.肝硬化患者甲状腺功能和尿碘水平的临床观察[J].2002,(6).
[5]黄重敏,黄春合,黄其文,等.重型肝炎病人甲状腺激素水平变化与临床意义[J].2004,(3).
[6]李谦,王喆,袁桂玉,等.重型肝炎甲状腺素检测及血浆置换对甲状腺素水平的影响[J].2007,(9).
[7]李艳萍,何兰杰.甲减性肝损害37例临床分析[J].2006,(3).
[8]中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南[J].2005,(6).
[9]刘勇钢.甲状腺机能亢进对戊型病毒性肝炎血清胆红素峰值的影响[J].2004,(2).
[10]中华医学会肝病学分会,中华医学会传染病与寄生虫病学分会.丙型肝炎防治指南[J].2004,(2).
[11]Edgar Selzer,Astrid Wilfing,Veronika SexlMichael Freissmuth.Effects of type I-interferons on human thyroid epithelial cells derived from normal and tumour tissue[J].1994,350(3).
[12]Naoki Sakane,Toshihide Yoshida,Keiji Yoshioka,etc.Reversible hypopituitarism after interferonalfa therapy[J].1995,345(8960).
[13]G Ghilardi,J J Gonvers,A So.Hypothyroid myopathy as a complication of interferon alpha therapy for chronic hepatitis C virus infection.[J].1998,37(12).
[14]Afdhal NH.The natural history of hepatitis C.[J].2004,24(Suppl.2).
[15]S, Katabami,K, Kamijo,T, Kodama,etc.An episode of silent thyroiditis in a patient with chronic thyroiditis and papillary adenocarcinoma following alpha interferon treatment for hepatitis C.[J].1993,40.
[16]M J, Huang,K L, Li,J S, Wei,etc.Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study.[J].1994,89.
[17]Ertu?rul, Kayacetin,Gurcan, Kisakol,Ahmet, Kaya.Low serum total thyroxine and free triiodothyronine in patients with hepatic encephalopathy due to non-alcoholic cirrhosis.[J].2003,133(13-14).
[18]R R, Cavalieri.The effects of nonthyroid disease and drugs on thyroid function tests.[J].1991,75(1).
[19]K, Oberg,I, Norheim,E, Lind,etc.Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results.[J].1986,70(11).
[20]Sorvillo F,Caporaso N,Amato G,etc.Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment.[J].2001,86(5).
[21]Rodien P,Madec A M,Ruf J,etc.Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies.[J].1996.
[22]S, Koizumi,Y, Mashio,H, Mizuo,etc.Graves' hyperthyroidism following transient thyrotoxicosis during interferon therapy for chronic hepatitis type C.[J].1995,34.
[23]J D, Yao,J B, Gross,J, Ludwig,etc.Cholestatic jaundice in hyperthyroidism.[J].1989,86(5).
[24]G, D'Amico,A, Fornasieri.Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus.[J].1995,25(3).
[25]A, Kawakami,K, Eguchi,N, Matsuoka,etc.Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro.[J].1996,137.
[26]S J, Hadziyannis.Skin diseases associated with hepatitis C virus infection.[J].1998,10(1).
[27]Chopra I. J..Euthyroid Sick Syndrome: Is It a Misnomer?[J].1997.
[28]S J, Hadziyannis.Nonhepatic manifestations and combined diseases in HCV infection.[J].1996,41.
[29]P L, Arscott,J, Knapp,M, Rymaszewski,etc.Fas (APO-1, CD95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor.[J].1997,138.
[30]Akriviadis EA,Xanthakis I,Navrozidou C,etc.Prevalence of cryoglobulinemia in chronic hepatitis C virus infection and response to treatment with interferon-alpha.[J].1997,25(4).
[31]G. P. Bianchi,M. Zoli,G. Marchesini,etc.Thyroid gland size and function in patients with cirrhosis of the liver[J].1991,11(2).
[32]Carella C.,Amato G.,Biondi B.,etc.Longitudinal Study of Antibodies against Thyroid in Patients Undergoing Interferon-α Therapy for HCV Chronic Hepatitis[J].1995,44(3).
[33]L, Fernandez-Soto,A, Gonzalez,F, Escobar-Jimenez,etc.Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.[J].1998,158.